Analgesics

Global Market Trajectory & Analytics

MCP-5064

EXECUTIVE ENGAGEMENTS

POOL

9928
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1392
Interactions with Platform & by Email

PARTICIPANTS

298
Unique # Participated

VALIDATIONS

96
Responses Validated*

COMPANIES

146
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

306

PAGES

578

EDITION

19

PRICE

USD 5450

CODE

MCP-5064


COMPETITIVE METRICS

COMPANY

D S N T

% *

A. Menarini Asia-Pacific Holdings Pte., Ltd.

Advance Pharmaceutical Inc.

AFT Pharmaceuticals Limited

Albemarle Corporation

Alpha First Aid Supplies Pty Limited

Alta Care Laboratoires S.R.L.

American Nutriceuticals, LLC

Amneal Pharmaceuticals, Inc.

Anabolic Laboratories LLC

Apotex, Inc.

View More...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Analgesics Market to Reach $59.2 Billion by 2026

Pain management continues to be one of the most sought-after treatment options for patients within the healthcare arena that underscores the critical significance of analgesics. Analgesics are drugs meant for pain control primarily. The drugs work on the CNS and peripheral nervous system for reducing or blocking pain sensitivity. There are also analgesics which work by preventing creation of pain mediating chemicals in the body. Widely used for treatment of mild to acute pain attributed to several medical conditions, injuries, surgeries and terminal disorders, analgesics have ruled the pain management domain for the past several decades. These medications have provided medical practitioners with an effective option to alleviate pain and help improve quality of life for patients. Amid the COVID-19 crisis, the global market for Analgesics estimated at US$45.1 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2026, growing at a CAGR of 4.7% over the analysis period. Prescription, one of the segments analyzed in the report, is projected to grow at a 4.4% CAGR to reach US$37.7 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the OTC segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 38.2% share of the global Analgesics market.

The U.S. Market is Estimated at $15.2 Billion in 2021, While China is Forecast to Reach $8.2 Billion by 2026

The Analgesics market in the U.S. is estimated at US$15.2 Billion in the year 2021. The country currently accounts for a 32.76% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$8.2 Billion in the year 2026 trailing a CAGR of 6.5% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.3% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR while Rest of European market (as defined in the study) will reach US$8.8 Billion by the close of the analysis period.

Growth in these markets are benefiting from increasing incidence of diseases like cancer, arthritis, CVD, and also other acute and chronic diseases which causes severe pain. Cancer pain, neuropathic pain, post-operative pain, and lower back pain represent the important market segments. Increasing incidence of cancer globally is poised to be a key driving force for market growth. Further, increasing prevalence of chronic diseases has also fostered the use of pain management therapeutics. Increasing innovation in the area, owing to increased research investment by drug development companies, for advancing combination of compounds for developing new and more effective analgesics with enhanced efficacy as well as fewer side effects, is another prominent factor contributing towards market growth.

Opioids Segment to Reach $18.4 Billion by 2026

Opioid analgesic drugs represent the gold standard in pain relieving treatment of critically ill patients across disease segments, including COVID-19. Fentanyl, morphine, and hydromorphone are among the most commonly used IV opioid analgesic drugs in the ICU settings for COVID as well as non-COVID patients. Global Opioids segment is estimated at US$14.9 Billion in 2020, and is projected to reach US$18.4 Billion by 2026 reflecting a compounded annual growth rate of 3.7% over the analysis period. United States constitutes the largest regional market for Opioids segment, accounting for 29.9% of the global sales in 2020. China is poised to register the fastest compounded annual growth rate of 5.2% over the analysis period, to reach US$2.6 Billion by 2026.

SELECT PLAYERS

Amneal Pharmaceuticals Inc; Apotex Inc; AstraZeneca Plc; Aurobindo Pharma Limited; Bausch Health Companies Inc.; Bayer AG; Cipla Limited; Eli Lilly and Company; Endo International plc; F. Hoffmann-La Roche AG; Fresenius Kabi AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC; Iroko Pharmaceuticals, LLC; Johnson & Johnson; Lupin Limited; Novartis AG; Reckitt Benckiser Group plc; Sanofi S.A.; Sun Pharmaceutical Industries Ltd; Teva Pharmaceutical Industries Ltd

SEGMENTS

» Drug Type (Prescription, OTC) » Drug Class (Opioids, NSAIDs, Other Drug Classes) » Route of Administration (Oral, Parenteral, Topical, Transdermal, Rectal)

GEOGRAPHIES

» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Spain » Russia » Rest of Europe » Asia-Pacific » Australia » India » South Korea » Rest of Asia-Pacific » Latin America » Argentina » Brazil » Mexico » Rest of Latin America » Middle East » Iran » Israel » Saudi Arabia » UAE » Rest of Middle East » Africa

TABLE OF CONTENTS

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
A Prelude to Analgesics
Analgesics: Perfect Therapeutic Options to Solve Mild to Crippling Pain
Key Segments
Opioid Analgesics
Non-Opioid Analgesics
Impact of COVID-19 on Analgesics
NSAIDs
NSAIDs Tend to Decrease Effectiveness of COVID-19 Vaccines, States a Yale University Study
Opioid
Acetaminophen
Global Analgesics Market to Witness Rapid Growth
Drugs Indicated for Pain Management
The US and Europe Represent the Largest Regions, Asia-Pacific to Witness fastest Growth
Non-Opioids: Fastest Growing Category
Competition
Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Growing Aging Population & Increasing Burden of Chronic Diseases Spurs
Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
EXHIBIT: Fatalities by Heart Conditions: Estimated Percentage Breakdown for Cardiovascular Disease, Ischemic Heart Disease, Stroke, and Others
EXHIBIT: Rising Diabetes Prevalence Presents Opportunity for Cell Surface Markers: Number of Adults (20-79) with Diabetes (in Millions) by Region for 2017 and 2045
Growing Incidence of Cancer and the Associated Pain to Drive the Analgesics Market
EXHIBIT: Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
EXHIBIT: Global Number of New Cancer Cases and Cancer-related Deaths by Cancer Site for 2018
EXHIBIT: Number of New Cancer Cases and Deaths (in Million) by Region for 2018
Advancements in Design and Delivery of Analgesic Drugs
Development of Safer Opioids with More Safer Profiles
Drug Pipeline with Efficacious Drugs
OTC Analgesics Market to Witness Fastest Growth
Topical Analgesics Market Holds Significant Share
Combination Therapies Gain Prominence
A Few Novel Analgesic Products under Development
E-commerce Platforms Strengthen Pharmaceutical Distribution in Crisis Period
Neuropathic Pain Management: Market with High Potential
Migraine Market: A Core Vertical in CNS Pain Management
Migraine Care: Select Patent Expiries (2013-2015)
Reyvow, Eli Lilly’s Novel Migraine Drug with the Potential to Lead the Global Migraine Medications Market
Three New Migraine Drugs Obtain FDA Approval
Eli Lilly’s Emgality Receives FDA Approval
Increasing Cases of Peripheral Nerve Injuries Drive the Analgesics Market
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Analgesics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027
World Current & Future Analysis for Prescription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Prescription by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Prescription by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for OTC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for OTC by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for OTC by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Opioids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Opioids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Other Drug Classes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Other Drug Classes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Transdermal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Transdermal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Transdermal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
World Current & Future Analysis for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World Historic Review for Rectal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
World 15-Year Perspective for Rectal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027
WORLD BRANDS
UNITED STATES
USA Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
USA Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
USA 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
CANADA
Canada Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Canada Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Canada 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
JAPAN
Japan Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Japan Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Japan 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
CHINA
China Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
China Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
China Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
China 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
EUROPE
Europe Current & Future Analysis for Analgesics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe Historic Review for Analgesics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027
Europe Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Europe Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Europe 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
FRANCE
France Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
France Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
France Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
France 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
GERMANY
Germany Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Germany Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Germany 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
ITALY
Italy Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Italy Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Italy 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
UK Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UK 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
SPAIN
Spain Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Spain Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Spain Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Spain 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
RUSSIA
Russia Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Russia Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Russia Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Russia 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Rest of Europe Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Europe 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Analgesics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Analgesics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Asia-Pacific Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Asia-Pacific 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
AUSTRALIA
Australia Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Australia Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Australia Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Australia 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
INDIA
India Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
India Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
India Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
India Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
India 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
SOUTH KOREA
South Korea Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
South Korea Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
South Korea Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
South Korea 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
REST OF ASIA-PACIFIC
Rest of Asia-Pacific Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Rest of Asia-Pacific Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Asia-Pacific Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Asia-Pacific 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
LATIN AMERICA
Latin America Current & Future Analysis for Analgesics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Latin America Historic Review for Analgesics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Latin America Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Latin America Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Latin America 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
ARGENTINA
Argentina Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Argentina Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Argentina Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Argentina 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
BRAZIL
Brazil Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Brazil Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Brazil Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Brazil 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
MEXICO
Mexico Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Mexico Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Mexico Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Mexico 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
REST OF LATIN AMERICA
Rest of Latin America Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Rest of Latin America Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Latin America Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Latin America 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
MIDDLE EAST
Middle East Current & Future Analysis for Analgesics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Middle East Historic Review for Analgesics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Analgesics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Middle East Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Middle East Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Middle East 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
IRAN
Iran Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Iran Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Iran Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Iran 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
ISRAEL
Israel Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Israel Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Israel Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Israel 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
SAUDI ARABIA
Saudi Arabia Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Saudi Arabia Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Saudi Arabia Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Saudi Arabia 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
UNITED ARAB EMIRATES
UAE Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
UAE Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UAE Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
UAE 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
REST OF MIDDLE EAST
Rest of Middle East Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Rest of Middle East Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Middle East Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Rest of Middle East 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
AFRICA
Africa Current & Future Analysis for Analgesics by Drug Type - Prescription and OTC - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Analgesics by Drug Type - Prescription and OTC Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Analgesics by Drug Type - Percentage Breakdown of Value Sales for Prescription and OTC for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Analgesics by Drug Class - Opioids, NSAIDs and Other Drug Classes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Analgesics by Drug Class - Percentage Breakdown of Value Sales for Opioids, NSAIDs and Other Drug Classes for the Years 2012, 2020 & 2027
Africa Current & Future Analysis for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Africa Historic Review for Analgesics by Route Of Administration - Oral, Parenteral, Topical, Transdermal and Rectal Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Africa 15-Year Perspective for Analgesics by Route Of Administration - Percentage Breakdown of Value Sales for Oral, Parenteral, Topical, Transdermal and Rectal for the Years 2012, 2020 & 2027
Total Companies Profiled: 146

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com